Technology area: Biotechnology & Pharmaceuticals
6 pending office actions • 6 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready
Unigen, Inc. has 6 pending office actions in Biotechnology & Pharmaceuticals. Each matter is assigned to a distinct examiner and a distinct art unit, creating a fully distributed examination pattern across the active workload.
COHEN, MICHAEL P is the busiest examiner, with 1 pending matter. Since the examiner assignments do not overlap, prosecution management should emphasize consistent claim positions and coordinated disclosure across matters rather than a single examiner-specific approach.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (33%) |
| §103 only | 2 (33%) |
| §112 only | 1 (17%) |
| Double-patenting + other | 1 (17%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| COHEN, MICHAEL P | 1 | 59.0% | +27.3% |
| SEITZ, ANTHONY JOSEPH | 1 | 68.2% | +26.9% |
| SCHACHERMEYER, SAMANTHA LYNN | 1 | 35.7% | +70.8% |
| RODRIGUEZ, RAYNA B | 1 | 33.5% | +19.2% |
| PARK, HAEJIN S | 1 | 55.1% | +38.3% |
| CHEN, CATHERYNE | 1 | 37.4% | +18.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18974365 | Natural Preservatives and Antimicrobial Agents, Including Compositions Thereof | COHEN, MICHAEL P | — |
| 18133294 | DIARYLALKANE COMPOUNDS AND COMPOSITIONS FOR USE WITH SKIN AGING AND METHODS OF PRODUCTION THEREOF | SEITZ, ANTHONY JOSEPH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17389001 | Standardized Bioflavonoid Composition for Regulation of Homeostasis of Host Defense Mechanism | RODRIGUEZ, RAYNA B | 60d overdue |
| 17164231 | COMPOSITIONS OF BAKUCHIOL AND METHODS OF MAKING THE SAME | CHEN, CATHERYNE | 60d overdue |
| 18113370 | COMPOSITIONS AND METHODS FOR JOINT HEALTH | SCHACHERMEYER, SAMANTHA LYNN | 18d overdue |
| 18974365 | Natural Preservatives and Antimicrobial Agents, Including Compositions Thereof | COHEN, MICHAEL P | — |
| 18133294 | DIARYLALKANE COMPOUNDS AND COMPOSITIONS FOR USE WITH SKIN AGING AND METHODS OF PRODUCTION THEREOF | SEITZ, ANTHONY JOSEPH | — |
| 17169490 | Compositions and Methods for Regulating Homeostasis of Chondrocytes, Extracellular Matrix, Articular Cartilage, and Phenotype of Arthritis | PARK, HAEJIN S | — |
| Art Unit | Apps |
|---|---|
| 1612 | 1 |
| 1629 | 1 |
| 1693 | 1 |
| 1628 | 1 |
| 1614 | 1 |
| 1655 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18974365 | Natural Preservatives and Antimicrobial Agents, Including Compositions Thereof | COHEN, MICHAEL P | 1612 | §101§103§112DP | Non-Final OA | — | Pending | Dec 09, 2024 |
| 18133294 | DIARYLALKANE COMPOUNDS AND COMPOSITIONS FOR USE WITH SKIN AGING AND METHODS OF PRODUCTION THEREOF | SEITZ, ANTHONY JOSEPH | 1629 | §101§102§103§112DP | Final Rejection | — | Pending | Apr 11, 2023 |
| 18113370 | COMPOSITIONS AND METHODS FOR JOINT HEALTH | SCHACHERMEYER, SAMANTHA LYNN | 1693 | §103 | Final Rejection | 18d overdue | Pending | Feb 23, 2023 |
| 17389001 | Standardized Bioflavonoid Composition for Regulation of Homeostasis of Host Defense Mechanism | RODRIGUEZ, RAYNA B | 1628 | §103§112DP | Final Rejection | 60d overdue | Pending | Jul 29, 2021 |
| 17169490 | Compositions and Methods for Regulating Homeostasis of Chondrocytes, Extracellular Matrix, Articular Cartilage, and Phenotype of Arthritis | PARK, HAEJIN S | 1614 | §112 | Final Rejection | — | Pending | Feb 07, 2021 |
| 17164231 | COMPOSITIONS OF BAKUCHIOL AND METHODS OF MAKING THE SAME | CHEN, CATHERYNE | 1655 | §103 | Final Rejection | 60d overdue | Pending | Feb 01, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUnigen, Inc. has 6 pending office actions as of November 2026, spread across 6 art units and 6 examiners.
Michael P Cohen has the most, with 1 of Unigen, Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.